Celltrion Inc (068270):企業の財務・戦略的SWOT分析

◆英語タイトル:Celltrion Inc (068270) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C2721
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥16,875見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥50,625見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Celltrion Inc (068270) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Celltrion Inc (Celltrion) is a biopharmaceutical company that focuses on research, development and manufacture of biosimilars and novel biopharmaceuticals. The company offers monoclonal antibodies for the treatment of rheumatoid arthritis, ankylosing spondylitis, ulcerative colitis, adult Crohn’s disease, psoriatic arthritis and psoriasis. Its pipeline portfolio spans monoclonal antibody biosmilars for the treatment of rheumatoid arthritis; colorectal cancer; large Intestine Cancer and respiratory disease; and antibody biologics for and vaccines for infectious diseases such as hepatitis B, influenza, rabies, breast cancer, seasonal influenza antibody; and antibody drug conjugates. Celltrion develops drugs by utilizing its bioengineering and mammalian cell-culture technology. The company also carries out contract manufacturing of biosimilars. It has operational presence in Korea, Russia, the UK, and the US. Celltrion is headquartered in Incheon city, South Korea.

Celltrion Inc Key Recent Developments

Jun 05,2018: Celltrion Launches Bio CDMO Business for the Development of New Drugs
Jan 30,2018: Celltrion’s Statement on Warning Letter Issued for its Drug Manufacturing Facility
Sep 26,2017: Celltrion taps Oracle Health Sciences Safety Solutions to Help Bring Cost-Effective Life-Saving and Biosimilar Drugs to Market

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Celltrion Inc – Key Facts 6
Celltrion Inc – Key Employees 7
Celltrion Inc – Major Products and Services 8
Celltrion Inc – History 9
Celltrion Inc – Company Statement 11
Celltrion Inc – Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2 – Company Analysis 13
Company Overview 13
Celltrion Inc – Business Description 14
Business Segment: Biopharmaceuticals Segment 14
Overview 14
Performance 14
Business Segment: Chemical Medicines Segment 14
Overview 14
Performance 14
Business Segment: Other Segment 14
Overview 14
Performance 15
R&D Overview 15
Celltrion Inc – SWOT Analysis 16
SWOT Analysis – Overview 16
Celltrion Inc – Strengths 16
Celltrion Inc – Weaknesses 17
Celltrion Inc – Opportunities 18
Celltrion Inc – Threats 19
Celltrion Inc – Key Competitors 20
Section 3 – Company Financial Ratios 21
Financial Ratios – Capital Market Ratios 21
Financial Ratios – Annual Ratios 22
Performance Chart 25
Financial Performance 25
Financial Ratios – Interim Ratios 26
Financial Ratios – Ratio Charts 27
Section 4 – Company’s Lifesciences Financial Deals and Alliances 28
Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29
Celltrion Inc, Recent Deals Summary 30
Section 5 – Company’s Recent Developments 31
Jun 05, 2018: Celltrion Launches Bio CDMO Business for the Development of New Drugs 31
Jan 30, 2018: Celltrion’s Statement on Warning Letter Issued for its Drug Manufacturing Facility 32
Sep 26, 2017: Celltrion taps Oracle Health Sciences Safety Solutions to Help Bring Cost-Effective Life-Saving and Biosimilar Drugs to Market 33
Section 6 – Appendix 34
Methodology 34
Ratio Definitions 34
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Celltrion Inc, Key Facts 6
Celltrion Inc, Key Employees 7
Celltrion Inc, Major Products and Services 8
Celltrion Inc, History 9
Celltrion Inc, Subsidiaries 12
Celltrion Inc, Key Competitors 20
Celltrion Inc, Ratios based on current share price 21
Celltrion Inc, Annual Ratios 22
Celltrion Inc, Annual Ratios (Cont...1) 23
Celltrion Inc, Annual Ratios (Cont...2) 24
Celltrion Inc, Interim Ratios 26
Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29
Celltrion Inc, Recent Deals Summary 30
Currency Codes 34
Capital Market Ratios 34
Equity Ratios 35
Profitability Ratios 35
Cost Ratios 36
Liquidity Ratios 36
Leverage Ratios 37
Efficiency Ratios 37

List of Figures
Celltrion Inc, Performance Chart (2013 - 2017) 25
Celltrion Inc, Ratio Charts 27
Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28
Celltrion Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 29

★海外企業調査レポート[Celltrion Inc (068270):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Touchstone Exploration Inc (TXP):企業の財務・戦略的SWOT分析
    Summary Touchstone Exploration Inc (Touchstone), formerly Touchstone Resources Ltd, is an upstream oil and gas exploration and production company. The company explores, produces, and develops, oil and gas properties in Trinidad and Tobago. It holds interests in projects such as South Palo Seco, New …
  • Protalex Inc (PRTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Protalex Inc (Protalex) is a biopharmaceutical company that develops drugs for the treatment of autoimmune and inflammatory diseases. The company offers treatment for a range of autoimmune diseases such as rheumatoid arthritis and immune thrombocytopenia. Its lead product candidate includes …
  • ZH International Holdings Ltd:企業の戦略・SWOT・財務情報
    ZH International Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary ZH International Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Securian Financial Group, Inc.:企業の戦略・SWOT・財務情報
    Securian Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Securian Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Fintel Energia Group SpA (FTL):企業の財務・戦略的SWOT分析
    Summary Fintel Energia Group SpA (Fintel) is a utility service provider that supplies electricity and natural gas. The company's services include designing, consultation, and installation of technologies and system of production of renewable energies for the Group and to third parties. It also provi …
  • LifeLabs Inc-医療機器分野:企業M&A・提携分析
    Summary LifeLabs Inc (LifeLabs) is a laboratory testing service provider that monitors heart disease and identifies neurological disorders and pinpoint allergies. The laboratory's services include clinical studies and services, drug and alcohol screening, employee wellness, hospital lab services, me …
  • Denbury Resources Inc.:企業の戦略・SWOT・財務分析
    Denbury Resources Inc. - Strategy, SWOT and Corporate Finance Report Summary Denbury Resources Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Exco Resources Inc (XCOOQ):石油・ガス:M&Aディール及び事業提携情報
    Summary Exco Resources Inc (Exco Resources) is an oil and gas company that offers crude oil and natural gas. The company offers acquisition, exploration, development, exploitation, operations, management, and production of onshore natural gas and oil assets. It provides services such as portfolio re …
  • Irish Life Assurance plc:企業の戦略・SWOT・財務分析
    Irish Life Assurance plc - Strategy, SWOT and Corporate Finance Report Summary Irish Life Assurance plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Ocado Group Plc:企業の戦略・SWOT・財務情報
    Ocado Group Plc - Strategy, SWOT and Corporate Finance Report Summary Ocado Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Adams Rite Aerospace, Inc.:企業の戦略・SWOT・財務情報
    Adams Rite Aerospace, Inc. - Strategy, SWOT and Corporate Finance Report Summary Adams Rite Aerospace, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Uponor Oyj:企業の戦略・SWOT・財務情報
    Uponor Oyj - Strategy, SWOT and Corporate Finance Report Summary Uponor Oyj - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Plantronics, Inc. (PLT):企業の財務・戦略的SWOT分析
    Plantronics, Inc. (PLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • OctreoPharm Sciences GmbH-医療機器分野:企業M&A・提携分析
    Summary OctreoPharm Sciences GmbH (OPS), a subsidiary of Ipsen SA is a clinical development biopharmaceutical company that develops radiopharmaceuticals for the diagnosis and therapeutic control of tumors. The company develops theranostic couple of antagonistic peptides for the diagnosis and treatme …
  • Enterome Bioscience SA-製薬・医療分野:企業M&A・提携分析
    Summary Enterome Bioscience SA (Enterome) is a drug development company that develops medical tests, and companion diagnostics to develop the management of microbiome-related diseases. The company develops medical tests based on its metagenotype technology platform that helps to identify microbiome- …
  • Bank of America Corp:企業の戦略・SWOT・財務分析
    Bank of America Corp - Strategy, SWOT and Corporate Finance Report Summary Bank of America Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • SNGN Romgaz SA (SNG):企業の財務・戦略的SWOT分析
    Summary SNGN Romgaz SA (Romgaz) is an oil and gas company which explores produces and supplies natural gas. The company's activities include exploration of petroleum onshore and offshore, natural gas production, electric power production, trading and technological transport. Romgaz through its well …
  • Pudumjee Paper Products Limited:企業の戦略・SWOT・財務分析
    Pudumjee Paper Products Limited - Strategy, SWOT and Corporate Finance Report Summary Pudumjee Paper Products Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Lotte Shopping Co., Ltd.:企業の戦略・SWOT・財務情報
    Lotte Shopping Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Lotte Shopping Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Alterna Savings and Credit Union Limited:企業の戦略・SWOT・財務情報
    Alterna Savings and Credit Union Limited - Strategy, SWOT and Corporate Finance Report Summary Alterna Savings and Credit Union Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆